Use of Human In Vitro Skin Models for Accurate and Ethical Risk Assessment: Metabolic Considerations
Authors:
- Nicola J. HewittNHNicola J. Hewitt
- Julia ScheelJSJulia Scheel
- Kerstin ReisingerKRKerstin Reisinger
- Daniel DucheDDDaniel Duche
- Joan EilsteinJEJoan Eilstein
- Julia KennyJKJulia Kenny
Open Access
- 28 March 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 133 (2) , 209-217
Abstract
Several human skin models employing primary cells and immortalized cell lines used as monocultures or combined to produce reconstituted 3D skin constructs have been developed. Furthermore, these models have been included in European genotoxicity and sensitization/irritation assay validation projects. In order to help interpret data, Cosmetics Europe (formerly COLIPA) facilitated research projects that measured a variety of defined phase I and II enzyme activities and created a complete proteomic profile of xenobiotic metabolizing enzymes (XMEs) in native human skin and compared them with data obtained from a number of in vitro models of human skin. Here, we have summarized our findings on the current knowledge of the metabolic capacity of native human skin and in vitro models and made an overall assessment of the metabolic capacity from gene expression, proteomic expression, and substrate metabolism data. The known low expression and function of phase I enzymes in native whole skin were reflected in the in vitro models. Some XMEs in whole skin were not detected in in vitro models and vice versa, and some major hepatic XMEs such as cytochrome P450-monooxygenases were absent or measured only at very low levels in the skin. Conversely, despite varying mRNA and protein levels of phase II enzymes, functional activity of glutathione S-transferases, N-acetyltransferase 1, and UDP-glucuronosyltransferases were all readily measurable in whole skin and in vitro skin models at activity levels similar to those measured in the liver. These projects have enabled a better understanding of the contribution of XMEs to toxicity endpoints.Keywords
This publication has 42 references indexed in Scilit:
- Elucidation of Xenobiotic Metabolism Pathways in Human Skin and Human Skin Models by Proteomic ProfilingPLOS ONE, 2012
- Effects of the genotoxic compounds, benzo[a]pyrene and cyclophosphamide on phase 1 and 2 activities in EpiDerm™ modelsXenobiotica, 2011
- Preferential Glutathione Conjugation of a Reverse Diol Epoxide Compared with a Bay Region Diol Epoxide of Benzo[a]pyrene in Human HepatocytesDrug Metabolism and Disposition, 2010
- Role of HuR and p38MAPK in Ultraviolet B-induced Post-transcriptional Regulation of COX-2 Expression in the Human Keratinocyte Cell Line HaCaTJournal of Biological Chemistry, 2010
- A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: Skin irritationRegulatory Toxicology and Pharmacology, 2009
- Cyclooxygenase-2 Expression during Immortalization and Breast Cancer ProgressionCancer Research, 2008
- Electrochemiluminescent Arrays for Cytochrome P450-Activated Genotoxicity Screening. DNA Damage from Benzo[a]pyrene MetabolitesAnalytical Chemistry, 2007
- Human cytosolic sulfotransferase 2B1: Isoform expression, tissue specificity and subcellular localizationThe Journal of Steroid Biochemistry and Molecular Biology, 2006
- Characterization of Glutathione S-Transferase in Cultured Human KeratinocytesJournal of Investigative Dermatology, 1991
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.Journal of Cell Biology, 1988